The DOI matches its Crossref record.
Pamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of Age
Open accessAbstract
Severe osteogenesis imperfecta (OI) is a hereditary disorder characterized by increased bone fragility and progressive bone deformity. Cyclical pamidronate infusions improve clinical outcome in children older than 3 yr of age with severe OI. Because earlier treatment may have potential to prevent deformities and improve functional prognosis in young children, we studied nine severely affected OI patients under 2 yr of age (2.3-20.7 months at entry) for a period of 12 months. Pamidronate was administered i.v. in cycles of 3 consecutive days. Patients received four to eight cycles during the treatment period, with cumulative doses averaging 12.4 mg/kg. Clinical changes were evaluated regularly during treatment, and radiological changes were assessed after 6-12 months of treatment. The control group consisted of six age-matched, severely affected OI patients, who had not received pamidronate treatment. During treatment bone mineral density (BMD) increased between 86-227%. The deviation from normal, as indicated by the z-score, diminished from -6.5 +/- 2.1 to -3.0 +/- 2.1 (P < 0.001). In the control group the BMD z-score worsened significantly. Vertebral coronal area increased in all treated patients (11.4 +/- 3.4 to 14.9 +/- 1.8 cm2; P < 0.001), but decreased in the untreated group (P < 0.05). In the treated patients, fracture rate was lower than in control patients (2.6 +/- 2.5 vs. 6.3 +/- 1.6 fractures/year; P < 0.01). No adverse side-effects were noted, apart from the well known acute phase reaction during the first infusion cycle. Pamidronate treatment in severely affected OI patients under 3 yr of age is safe, increases BMD, and decreases fracture rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta
Horwitz, E. M., Prockop, D. J., Gordon, P. L., Koo, W. W. K., Fitzpatrick, L. A., Neel, M. D., McCarville, M. E., Orchard, P. J., Pyeritz, R. E., & Brenner, M. K. (2001) · Blood · doi:10.1182/blood.v97.5.1227 · Cited by 571
Rauch, F., Travers, R., Plotkin, H., & Glorieux, F. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15952 · Cited by 291
Self-citationBeneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
Astrom, E. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.5.356 · Cited by 259
Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment
Rudge, S., Hailwood, S., Horne, A., Lucas, J., Wu, F., & Cundy, T. (2005) · Rheumatology · doi:10.1093/rheumatology/keh538 · Cited by 108
Metadata
- Authors
- Plotkin, H.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-05-01
- Volume
- 85
- Issue
- 5
- Pages
- 1846-1850
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2144386867
- Cited by
- 315
- References
- 0
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of Age. https://app.cochat.ai/papers/10.1210/jc.85.5.1846
- The paper
- Plotkin, H. (2000). Pamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of Age. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.85.5.1846
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.